Eikon Therapeutics, Inc. (EIKN)
9.21
-1.52
(-14.17%)
USD |
NASDAQ |
Sep 10, 16:00
9.19
-0.02
(-0.22%)
After-Hours: 04:41
Eikon Therapeutics Price to Book Value : 1.069 for Sept. 10, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 10, 2026 | 1.069 |
| September 09, 2026 | 1.246 |
| September 08, 2026 | 1.243 |
| September 04, 2026 | 1.261 |
| September 03, 2026 | 1.272 |
| September 02, 2026 | 1.321 |
| September 01, 2026 | 1.263 |
| August 31, 2026 | 1.214 |
| August 28, 2026 | 1.274 |
| August 27, 2026 | 1.337 |
| August 26, 2026 | 1.391 |
| August 25, 2026 | 1.457 |
| August 24, 2026 | 1.295 |
| August 21, 2026 | 1.322 |
| August 20, 2026 | 1.248 |
| August 19, 2026 | 1.394 |
| August 18, 2026 | 1.352 |
| August 17, 2026 | 1.215 |
| August 14, 2026 | 1.283 |
| August 13, 2026 | 1.199 |
| August 12, 2026 | 1.210 |
| August 11, 2026 | 1.187 |
| August 10, 2026 | 1.129 |
| August 07, 2026 | 1.078 |
| August 06, 2026 | 1.069 |
| Date | Value |
|---|---|
| August 05, 2026 | 1.108 |
| August 04, 2026 | 1.110 |
| August 03, 2026 | 1.062 |
| July 31, 2026 | 1.069 |
| July 30, 2026 | 1.117 |
| July 29, 2026 | 1.046 |
| July 28, 2026 | 1.102 |
| July 27, 2026 | 1.147 |
| July 24, 2026 | 1.033 |
| July 23, 2026 | 1.117 |
| July 22, 2026 | 1.116 |
| July 21, 2026 | 1.150 |
| July 20, 2026 | 1.120 |
| July 17, 2026 | 1.134 |
| July 16, 2026 | 1.155 |
| July 15, 2026 | 1.142 |
| July 14, 2026 | 1.183 |
| July 13, 2026 | 1.212 |
| July 10, 2026 | 1.228 |
| July 09, 2026 | 1.302 |
| July 08, 2026 | 1.244 |
| July 07, 2026 | 1.346 |
| July 06, 2026 | 1.396 |
| July 02, 2026 | 1.456 |
| July 01, 2026 | 1.422 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.654 |
| Alnylam Pharmaceuticals, Inc. | 24.44 |
| Anika Therapeutics, Inc. | 2.046 |
| Savara, Inc. | 7.606 |
| Vericel Corp. | 5.237 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0101 |
| Price | 9.21 |
| Earnings Yield | -71.44% |
| Market Cap | 498.71M |
| PEGY Ratio | -0.0101 |